niraparib plus PD-1 inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for niraparib plus PD-1 inhibitors, covering 2021-07-07 to 2021-07-07. Get the full timeline:
Most recent: Clinical Trial Update: Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants [Phase 2]